Background and purpose: Raloxifene improves cardiovascular function. This study examines the hypothesis that therapeutic concentrations of raloxifene augment endothelium-dependent relaxation via up-regulation of eNOS expression and activity in porcine coronary arteries. Experimental approach: Isometric tension was measured in rings from isolated arteries. Intracellular Ca 2 þ concentrations ([Ca 2 þ ] i ) in arterial endothelial cells were detected by Ca 2 þ fluorescence imaging. Phosphorylation of eNOS at Ser-1177 was assayed by Western blot analysis. Key results: In arterial rings pre-contracted with 9,11-dideoxy-11a,9a-epoxy-methano-prostaglandin F 2a (U46619), treatment with raloxifene (1-3 nM) augmented bradykinin-or substance P-induced relaxation and this effect was antagonized by ICI 182,780, an estrogen receptor antagonist. The enhanced relaxation was abolished in rings treated with inhibitors of nitric oxide/cyclic GMP-dependent dilation, N G -nitro-L-arginine methyl ester (L-NAME) plus 1H-[1,2,4]oxadizolo[4,3-a]quinoxalin-1-one (ODQ). In contrast, effects of raloxifene were unaffected after inhibition of endothelium-derived hyperpolarizing factors by charybdotoxin plus apamin. Raloxifene (3 nM) did not influence endothelium-independent relaxation to sodium nitroprusside. 17 -Estradiol (3-10 nM) also enhanced bradykinin-induced relaxation, which was inhibited by ICI 182,780. Treatment with raloxifene (3 nM) did not affect bradykinin-stimulated rise in endothelial cell [Ca 2 þ ] i . Raloxifene, 17 -estradiol, and bradykinin increased eNOS phosphorylation at Ser-1177 and ICI 182,780 prevented effects of raloxifene or 17 -estradiol but not that of bradykinin. Raloxifene had neither additive nor antagonistic effects on 17 -estradiol-induced eNOS phosphorylation. Conclusions and implications: Raloxifene in therapeutically relevant concentrations augmented endothelial function in porcine coronary arteries in vitro through ICI 182,780-sensitive mechanisms that were associated with increased phosphorylation of eNOS but independent of changes in endothelial cell [Ca 2 þ ] i .